You are viewing a free limited preview of OPX Biotechnologies, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access

OPX Biotechnologies, Inc.

Private Company Ticker Symbol™: (OPXBIOP)
What's included with your PrivCo Report Purchase:
Next Actions on OPX Biotechnologies, Inc.:
Full Online ReportAdobe PDFDownload PDF ReportMicrosoft ExcelExport FinancialsSee Industry M&A ActivitySee Industry VC Activity

Business Summary

OPX Biotechnologies, Inc. is a privately held biotechnology company that engages in the production of biofuels and chemicals. It operates its business through EDGE technology (Efficiency Directed Genome Engineering). Founded in 2007, OPX Biotechnologies, Inc. is headquartered in Boulder, Colorado.

Overview & Corporate Organization

Basic Information

Company Tags:PE Backed
VC Backed
Year Founded:2007
Fiscal Year End:12/31
City:Boulder
State/Province:Colorado
Country:United States
Phone:View
Website:www.opxbiotechnologies.com

Corporate Organization

Brands:
EDGE

Industry Information

Industry Codes

PICS™:200299™, 1000303™
NAICS:View
SIC:View

PrivCo Industries (Sector > Industry > Sub-Industry)

Clean Energy Technology > Biofuels > Other Biofuels
Manufacturing & Industrial > Chemical Manufacturing > Biochemicals

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

VC/Funding Activity

PrivCo's VC/Funding Activity table for OPX Biotechnologies, Inc. displays the venture capital rounds, angel investments, debt or other funding raised by OPX Biotechnologies, Inc..
All data before 2006 is completely free to view! To access data from 2006 onward:
Get Full Access To This Report Now! $99 Single Company Access
  or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateInvestorRoundInvestor Type
Dec. 2007ViewAVenture Capital
Dec. 2007ViewAVenture Capital
DetailsTotal Round A View
Jun. 2008ViewOther
DetailsTotal Round Other View
Apr. 2009ViewBVenture Capital
Apr. 2009ViewBVenture Capital
Apr. 2009ViewBVenture Capital
Apr. 2009ViewBVenture Capital
DetailsTotal Round B View
Jul. 2011ViewCPrivate Equity
Jul. 2011ViewCVenture Capital
Jul. 2011ViewCVenture Capital
Jul. 2011ViewCVenture Capital
Jul. 2011ViewCVenture Capital
Jul. 2011ViewCVenture Capital
DetailsTotal Round C View
Total of Funding Shown Above View

Missing a deal? Tell us about it! tips@privco.com

Supplemental Resources

For additional information on OPX Biotechnologies, Inc., you can see the following:
What's included with your PrivCo Report Purchase:
Next Actions on OPX Biotechnologies, Inc.:
Full Online ReportAdobe PDFDownload PDF ReportMicrosoft ExcelExport FinancialsSee Industry M&A ActivitySee Industry VC Activity
  • Learn More About PrivCo
  • PrivCo’s Clients Include:
  • Clients Include: Motorola, 3M, Samsung, Oracle, TATA, Johnson and Johnson, CB Richard Ellis
  • PrivCo Is Featured In:
  • Featured In: The New York Times, New York Post, Bloomberg, CNBC, NPR, The Washington Post, The Wall Street Journal, CNN, Fortune, BusinessWeek, Reuters, CBS News, USA Today
PrivCo’s 300-page Private Company Tech M&A Report for 2012 - Click Here For Full Report
  • Quick Private Co. Search

within miles
 

Annual Revenues search is available on PrivCo Premium.

Upgrade to PrivCo Premium Subscription
Go to Advanced Search
  • What is PrivCo?

PrivCo is the authority for financial & business data on major private companies, including:

PrivCo Private Deals Newsletter.
It's FREE!

You are viewing a free limited preview of OPX Biotechnologies, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access